1. Home
  2. VYNE vs SYT Comparison

VYNE vs SYT Comparison

Compare VYNE & SYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYNE
  • SYT
  • Stock Information
  • Founded
  • VYNE 2003
  • SYT 2010
  • Country
  • VYNE United States
  • SYT Japan
  • Employees
  • VYNE N/A
  • SYT N/A
  • Industry
  • VYNE Biotechnology: Pharmaceutical Preparations
  • SYT Real Estate
  • Sector
  • VYNE Health Care
  • SYT Finance
  • Exchange
  • VYNE Nasdaq
  • SYT Nasdaq
  • Market Cap
  • VYNE 41.9M
  • SYT 40.2M
  • IPO Year
  • VYNE 2018
  • SYT 2023
  • Fundamental
  • Price
  • VYNE $2.90
  • SYT $1.63
  • Analyst Decision
  • VYNE Strong Buy
  • SYT
  • Analyst Count
  • VYNE 2
  • SYT 0
  • Target Price
  • VYNE $6.88
  • SYT N/A
  • AVG Volume (30 Days)
  • VYNE 122.3K
  • SYT 8.1K
  • Earning Date
  • VYNE 11-07-2024
  • SYT 09-27-2024
  • Dividend Yield
  • VYNE N/A
  • SYT 0.42%
  • EPS Growth
  • VYNE N/A
  • SYT N/A
  • EPS
  • VYNE N/A
  • SYT 0.08
  • Revenue
  • VYNE $493,000.00
  • SYT $149,124,408.00
  • Revenue This Year
  • VYNE $32.31
  • SYT N/A
  • Revenue Next Year
  • VYNE N/A
  • SYT N/A
  • P/E Ratio
  • VYNE N/A
  • SYT $20.69
  • Revenue Growth
  • VYNE 39.27
  • SYT 3.11
  • 52 Week Low
  • VYNE $1.57
  • SYT $1.43
  • 52 Week High
  • VYNE $4.09
  • SYT $8.74
  • Technical
  • Relative Strength Index (RSI)
  • VYNE 59.02
  • SYT 49.92
  • Support Level
  • VYNE $2.65
  • SYT $1.58
  • Resistance Level
  • VYNE $3.05
  • SYT $1.84
  • Average True Range (ATR)
  • VYNE 0.23
  • SYT 0.09
  • MACD
  • VYNE -0.05
  • SYT 0.02
  • Stochastic Oscillator
  • VYNE 34.57
  • SYT 43.24

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

About SYT SYLA Technologies Co. Ltd.

SYLA Technologies Co Ltd is a property technology company. It provides asset management platform systems that facilitate real estate crowd-funding as well as the purchase and sale of real estate.

Share on Social Networks: